Intellego Technologies

Intellego enters negotiations with global pharma group

Intellego has initiated negotiations with one of the world’s largest companies in the pharmaceutical consumables and production sector. This US-based company has over 10,000 employees and operates in more than 150 countries. It is a subsidiary of one of the world’s leading pharmaceutical groups, which employs over 80,000 people globally.

The company has spent the past nine months evaluating Intellego’s UV LED dosimeters and the market, yielding positive results. The aim of this collaboration is to launch Intellego’s UV LED dosimeters, and potentially other dosimeter products, on the global market which has an estimated value of EUR 2 billion per year.

The launch is planned for 2025, with sales expected to increase progressively over time.

Datum 2024-11-20, kl 10:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!